Analysis of the European Hepatitis B and C Therapeutics Markets

Analysis of the European Hepatitis B and C Therapeutics Markets

Emerging Combinatorial Therapeutics is the Future Market

RELEASE DATE
18-Feb-2013
REGION
North America
Research Code: M8B9-01-00-00-00
SKU: LS00091-NA-MR_16932
$4,950.00
In stock
SKU
LS00091-NA-MR_16932
$4,950.00
Links

Pay by invoice

ENQUIRE NOW

Description

This research service gives an in-depth analysis of what lies next for the Hepatitis B and C therapeutics markets. This research service covers, the key trends, drivers, restraints, revenue forecasts and competitive analysis of the Hepatitis B and C therapeutics market along with the respective segments such as interferons, nucleoside analogues for Hepatitis B and SOC, protease inhibitors for Hepatitis C. A comprehensive European Regional analysis (The United Kingdom, Germany, France, Italy, Spain, Benelux and Scandinavia) and regional policy implications have also been provided.

Table of Contents

Executive Summary

Executive Summary—Market Engineering Measurements

Executive Summary—Market Engineering Measurements (continued)

Executive Summary—Market Engineering Measurements (continued)

Executive Summary—Market Engineering Measurements (continued)

Executive Summary—CEO’s Perspective

Market Overview—Disease Overview

Market Overview—Disease Overview (continued)

Market Overview—Hepatitis B Definitions

Market Overview—Key Questions This Study Will Answer

Market Overview—Market Segmentation

Market Overview—Geographic Segmentation

Drivers and Restraints

Drivers Explained

Drivers Explained (continued)

Drivers Explained (continued)

Restraints Explained

Restraints Explained (continued)

Restraints Explained (continued)

Restraints Explained (continued)

Impact Mapping of Drivers and Restraints

Market Engineering Measurements

Market Engineering Measurements (continued)

Forecast Assumptions

Hepatitis B Therapeutics Market—Revenue Forecast

Hepatitis B Therapeutics Market—Revenue Forecast Discussion

Hepatitis B Therapeutics Market—Revenue Forecast by Drug Class

Hepatitis B Therapeutics Market—Revenue Forecast by Region

Hepatitis B Therapeutics Market—Revenue Forecast by Region

HBV Surveillance System

HBV Surveillance System (continued)

Hepatitis B Therapeutics Market—Metrics Analysis

Market Engineering Measurements

Market Engineering Measurements (continued)

Hepatitis C Therapeutics Market—Revenue Forecast

Hepatitis C Therapeutics Market—Revenue Forecast Discussion

Hepatitis C Therapeutics Market—Revenue Forecast by Drug Class

Hepatitis C Therapeutics Market—Revenue Forecast by Region

Hepatitis C Therapeutics Market—Revenue Forecast by Region (continued)

HCV Surveillance System

HCV Surveillance System (continued)

Hepatitis C Therapeutics Market—Metrics Analysis

PEST Analysis

Hepatitis B—Infection Prevalence Analysis

Hepatitis C—Infection Prevalence Analysis

Competitive Analysis—Market Share

Market Share Analysis

Competitive Environment

Competitive Analysis—Market Share

Market Share Analysis

Competitive Environment

Hepatitis B—Key Marketed Product Analysis

Hepatitis B—Key Pipeline Analysis

Hepatitis B—Key Pipeline Analysis (continued)

Hepatitis C—Marketed Product Analysis

Hepatitis C—Marketed Product Analysis (continued)

Hepatitis C—Key Pipeline Analysis Pipeline Analysis

Hepatitis C—Key Pipeline Analysis—Interferon-free Combinations

Interferons Segment Breakdown

Interferons Segment—Market Engineering Measurements

Interferons Segment—Revenue Forecast

Interferons Segment—Revenue Forecast Discussion

Interferons Segment—Impact of Key Market Trends

Nucleoside Analogues Segment Breakdown

Nucleoside Analogues Segment—Market Engineering Measurements

Nucleoside Analogues Segment—Revenue Forecast

Nucleoside Analogues Segment—Revenue Forecast Discussion

Nucleoside Analogues Segment—Impact of Key Market Trends

SOC Segment Breakdown

SOC Segment—Market Engineering Measurements

SOC Segment—Revenue Forecast

SOC Segment—Revenue Forecast Discussion

SOC Segment—Impact of Key Market Trends

Protease Inhibitors Segment Breakdown

Protease Inhibitors Segment—Market Engineering Measurements

Protease Inhibitors Segment—Revenue Forecast

Protease Inhibitors Segment—Revenue Forecast Discussion

Protease Inhibitors Segment—Impact of Key Market Trends

UK Market—Introduction

UK Hepatitis B Therapeutics Market—Market Engineering Measurements

UK Hepatitis B Therapeutics Market—Revenue Forecast

UK Hepatitis C Therapeutics Market—Market Engineering Measurements

UK Hepatitis C Therapeutics Market—Revenue Forecast

UK Hepatitis B and Hepatitis C Therapeutics Markets—Revenue Forecast Discussion

UK Hepatitis B and C Therapeutics Markets—Policies and Implications

German Market—Introduction

German Hepatitis B Therapeutics Market—Market Engineering Measurements

German Hepatitis B Therapeutics Market—Revenue Forecast

German Hepatitis C Therapeutics Market—Market Engineering Measurements

German Hepatitis C Therapeutics Market—Revenue Forecast

German Hepatitis B and Hepatitis C Drugs Markets—Revenue Forecast Discussion

German Hepatitis B and Hepatitis C Therapeutics Markets —Policies and Implications

French Market—Introduction

French Hepatitis B Therapeutics Market—Market Engineering Measurements

French Hepatitis B Therapeutics Market—Revenue Forecast

French Hepatitis C Therapeutics Market—Market Engineering Measurements

French Hepatitis C Therapeutics Market—Revenue Forecast

French Hepatitis B and Hepatitis C Therapeutics Markets—Revenue Forecast Discussion

French Hepatitis B and C Therapeutics Markets—Policies and Implications

Spanish Market—Introduction

Spanish Hepatitis B Therapeutics Market—Market Engineering Measurements

Spanish Hepatitis B Therapeutics Market—Revenue Forecast

Spanish Hepatitis C Therapeutics Market—Market Engineering Measurements

Spanish Hepatitis C Therapeutics Market—Revenue Forecast

Spanish Hepatitis B and Hepatitis C Therapeutics Markets—Revenue Forecast Discussion

Spanish Hepatitis B and C Therapeutics Markets—Policies and Implications

The Italian Market—Introduction

Italian Hepatitis B Therapeutics Market—Market Engineering Measurements

Italian Hepatitis B Therapeutics Market—Revenue Forecast

Italian Hepatitis C Therapeutics Market—Market Engineering Measurements

Italian Hepatitis C Therapeutics Market—Revenue Forecast

Italian Hepatitis B and Hepatitis C Therapeutics Markets—Revenue Forecast Discussion

Italian Hepatitis B and C Therapeutics Markets—Policies and Implications

Benelux Market—Introduction

Benelux Hepatitis B Therapeutics Market—Market Engineering Measurements

Benelux Hepatitis B Therapeutics Market—Revenue Forecast

Benelux Hepatitis C Therapeutics Market—Market Engineering Measurements

Benelux Hepatitis C Therapeutics Market—Revenue Forecast

Benelux Hepatitis B and Hepatitis C Therapeutics Markets—Revenue Forecast Discussion

Belgium Hepatitis B and C Therapeutics Markets—Policies and Implications

The Netherlands Hepatitis B and C Therapeutics Markets—Policies and Implications (continued)

Luxembourg Hepatitis B and C Therapeutics Markets—Policies and Implications

Scandinavian Market—Introduction

Scandinavia Hepatitis B Therapeutics Market—Market Engineering Measurements

Scandinavia Hepatitis B Therapeutics Market—Revenue Forecast

Scandinavia Hepatitis C Therapeutics Market—Market Engineering Measurements

Scandinavia Hepatitis C Therapeutics Market—Revenue Forecast

Scandinavia Hepatitis B and Hepatitis C Therapeutics Markets—Revenue Forecast Discussion

Norway Hepatitis B and C Therapeutics Markets—Policies and Implications

Denmark Hepatitis B and C Therapeutics Markets—Policies and Implications

Finland Hepatitis B and C Therapeutics Markets—Policies and Implications

Sweden Hepatitis B and C Therapeutics Markets—Policies and Implications

Conclusions—Hepatitis B and C Therapeutics Markets

The Last Word—Three Big Predictions

Legal Disclaimer

Market Engineering Methodology

Database of Key Industry Participants

Additional Sources of Information

Table of Acronyms Used

Incidence of Hepatitis B

Liver Failure Deaths

Government Healthcare Expenditure

Total Healthcare Expenditure

Related Research

2016-17 Outlook for Indian Agriculture and Rural Demand

Release Date: 18-May-16
Region: Global

Monthly CPI & WPI Inflation, April 2016

Release Date: 18-May-16
Region: Global

India Investment Tracker January–March 2016

Release Date: 18-May-16
Region: South Asia, Middle East & North Africa

Country Profile – Russia

Release Date: 13-May-16
Region: Asia Pacific

North American Protein Ingredients Market, Forecast to 2020

Release Date: 13-May-16
Region: North America

Global Economic Tracker—Insights and Trends (GET-IT)—Emerging Middle East and Africa Q2 2016

Release Date: 12-May-16
Region: South Asia, Middle East & North Africa

Middle East and North Africa Investment Tracker January-March 2016

Release Date: 11-May-16
Region: South Asia, Middle East & North Africa

Asia-Pacific Telehealth Market Outlook, Forecast to 2020

Release Date: 11-May-16
Region: Asia Pacific

Digital Transformation in the Global Food & Agriculture Market

Release Date: 9-May-2016
Region: North America
The marketed and development product landscape for diabetes therapeutics is becoming crowded with multiple products with little differentiation. However, there is still ample room for growth through the introduction of novel therapies that fill therapeutic gaps left by available products. Comprehensive information on market background and global overview and analysis of drug development, detailed product and pipeline analysis by market segment, drug class, and stage of development, and detailed product profiles for key marketed and late-stage products is included in the study. Also included are time-sensitive details such as new product launch timelines, cardiovascular outcomes trials timelines, and patent expirations.
More Information
No Index Yes
Podcast No
Author Deepika Pramod Chopda
WIP Number M8B9-01-00-00-00
Is Prebook No